the analyticalprocedure was applied to pharmaceutical formulations,
such as Genta-Gobens® (Normon, Spain), Oftalmolosa Cusi
Gentamicina® (Alcon Cusi, Spain) and Colircus´ı Gentamicina
1® (Alcon Cusi, Spain). A t-test was applied to compare if the
nominal values (claimed on the formulation label) were similar
to the obtained average from the application of the proposed
method. The results are shown in Table 4.As can be seen, no significant
differences were found between the compared values,
being the method applicable to these pharmaceutical formulations.